Edan Instruments Hits Day Low of CNY 12.98 Amid Price Pressure

Edan Instruments, Inc., a small-cap player in the Pharmaceuticals & Biotechnology sector, experienced a significant decline today, with its stock price dropping by 8.4%. The stock reached an intraday low of CNY 12.98, reflecting a challenging trading session compared to the broader market, as the China Shanghai Composite index fell by 3.63%. Over the past week, Edan Instruments has seen a decline of 11.2%, and its performance over the last month shows a decrease of 9.98%. Despite these short-term challenges, the company has demonstrated resilience over the past year, with a return of 7.48%, although this lags behind the China Shanghai Composite's 13.33% gain. Financially, Edan Instruments reported a robust net profit growth of 14.34% in its latest results, alongside a notable operating cash flow of CNY 348.33 million. The company maintains a healthy cash position with CNY 2,210.32 million in cash and equivalents. With a return on equity of 11.58% and a price-to-book ratio of 2.33, Edan Instruments continues to navigate a competitive landscape while facing current market pressures.